Skip to main content
Livermore
Livermore
ZHEN

Artal Group S.A.

SEC CIK
0001053906
Latest filing
Aug 13, 2026

Holdings in Q2 2024

Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.

Institution overview
Positions
109
+2 vs. Q1 2024
Portfolio value
$3.89B
+$14.9M (+0.4%) vs. Q1 2024
Filed
Aug 14, 2024
SEC
Holdings of Artal Group S.A. in Q2 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
CAVACava Group, Inc.COM23,507,990$2.18B56.0%−3,000,000−11.3%ReducedHistory
LXRXLexicon Pharmaceuticals, Inc.COM NEW175,099,384$294.2M7.6%+57,546,100+49.0%AddedHistory
SRRKScholar Rock Holding CorpCOM11,259,438$93.8M2.4%00.0%UnchangedHistory
KYMRKymera Therapeutics, Inc.COM3,005,610$89.7M2.3%−21,525−0.7%ReducedHistory
MORFMorphic Holding, Inc.COM2,525,998$86.1M2.2%+312,810+14.1%AddedHistory
ARWRArrowhead Pharmaceuticals, Inc.COM3,189,389$82.9M2.1%+152,721+5.0%AddedHistory
APLSApellis Pharmaceuticals, Inc.COM1,467,080$56.3M1.4%+151,798+11.5%AddedHistory
DYNDyne Therapeutics, Inc.COM1,516,960$53.5M1.4%−1,000−0.1%ReducedHistory
SLNSilence Therapeutics plcADS2,779,619$52.8M1.4%00.0%UnchangedHistory
SWTXSpringWorks Therapeutics, Inc.COM1,313,026$49.5M1.3%−102,322−7.2%ReducedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM1,066,064$47.7M1.2%−324,413−23.3%ReducedHistory
MRUSMerus N.V.COM760,355$45.0M1.2%+305,274+67.1%AddedHistory
ONCBeOne Medicines Ltd.ADR303,369$43.3M1.1%−101,413−25.1%ReducedHistory
RVMDRevolution Medicines, Inc.COM1,015,776$39.4M1.0%−302,873−23.0%ReducedHistory
KURAKura Oncology, Inc.COM1,819,884$37.5M1.0%−100,000−5.2%ReducedHistory
VERAVera Therapeutics, Inc.CL A915,974$33.1M0.9%+409,955+81.0%AddedHistory
NMRANeumora Therapeutics, Inc.COM2,824,052$27.8M0.7%−100,000−3.4%ReducedHistory
CYTKCytokinetics IncCOM NEW494,421$26.8M0.7%−12,163−2.4%ReducedHistory
Avidity Biosciences, Inc.05370A108COM655,555$26.8M0.7%+655,555New–
IGMSIGM Biosciences, Inc.COM3,330,422$22.9M0.6%+250,000+8.1%AddedHistory
WVEWave Life Sciences, Inc.SHS4,566,251$22.8M0.6%+514,851+12.7%AddedHistory
ERASErasca, Inc.COM9,630,810$22.7M0.6%+4,909,616+104.0%AddedHistory
TNGXTango Therapeutics, Inc.COM2,519,841$21.6M0.6%+325,000+14.8%AddedHistory
PRTAProthena Corp Public Ltd CoSHS1,001,360$20.7M0.5%00.0%UnchangedHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS2,112,500$19.1M0.5%+700,000+49.6%AddedHistory
CGEMCullinan Therapeutics, Inc.COM1,057,949$18.5M0.5%+1,057,949NewHistory
NAMSNewAmsterdam Pharma Co N.V.ORDINARY SHARES800,000$15.4M0.4%00.0%UnchangedHistory
XENEXenon Pharmaceuticals Inc.COM381,554$14.9M0.4%+128,167+50.6%AddedHistory
EWTXEdgewise Therapeutics, Inc.COM811,718$14.6M0.4%00.0%UnchangedHistory
SLDBSolid Biosciences Inc.COM NEW2,500,000$14.2M0.4%00.0%UnchangedHistory
KRROKorro Bio, Inc.COM413,072$14.0M0.4%−6,154−1.5%ReducedHistory
ASNDAscendis Pharma A/SSPONSORED ADR101,100$13.8M0.4%+101,100NewHistory
AGENAgenus IncCOM NEW775,000$13.0M0.3%−6,562−0.8%ReducedConverted for a 1-for-20 splitHistory
SYRSSyros Pharmaceuticals, Inc.COM NEW2,505,013$12.9M0.3%00.0%UnchangedHistory
GOSSGossamer Bio, Inc.COM13,308,968$12.0M0.3%00.0%UnchangedHistory
DNLIDenali Therapeutics Inc.COM502,899$11.7M0.3%00.0%UnchangedHistory
RAREUltragenyx Pharmaceutical Inc.COM275,000$11.3M0.3%+97,068+54.6%AddedHistory
BHVNBiohaven Ltd.COM306,703$10.6M0.3%+306,703NewHistory
TSHATaysha Gene Therapies, Inc.COM SHS4,354,214$9.75M0.3%+666,666+18.1%AddedHistory
LXEOLexeo Therapeutics, Inc.COM603,435$9.68M0.2%−198,281−24.7%ReducedHistory
SLRNACELYRIN, Inc.COM2,020,888$8.91M0.2%−384,255−16.0%ReducedHistory
JANXJanux Therapeutics, Inc.COM203,000$8.50M0.2%+153,000+306.0%AddedHistory
RNACCartesian Therapeutics, Inc.COM NEW304,554$8.23M0.2%+304,554NewHistory
RAPPRapport Therapeutics, Inc.COM350,000$8.14M0.2%+350,000NewHistory
IOVAIovance Biotherapeutics, Inc.COM1,011,500$8.11M0.2%+1,011,500NewHistory
GBIOGeneration Bio Co.COM2,830,591$7.98M0.2%00.0%UnchangedHistory
SEERSeer, Inc.COM CL A4,750,000$7.98M0.2%00.0%UnchangedHistory
VIGLVigil Neuroscience, Inc.COM1,828,691$7.31M0.2%+17,500+1.0%AddedHistory
DFTXDefinium Therapeutics, Inc.Stock1,007,875$7.27M0.2%+1,007,875NewHistory
SESea LtdSPONSORD ADS97,500$6.96M0.2%−140,000−58.9%ReducedHistory
PDDPDD Holdings Inc.SPONSORED ADS45,500$6.05M0.2%−11,000−19.5%ReducedHistory
NVDANVIDIA CorpStock43,000$5.31M0.1%+24,000+126.3%AddedConverted for a 10-for-1 splitHistory
MSFTMicrosoft CorpStock11,300$5.05M0.1%+8,800+352.0%AddedHistory
VVisa Inc.Stock19,000$4.99M0.1%+16,500+660.0%AddedHistory
BDTXBlack Diamond Therapeutics, Inc.COM1,046,517$4.88M0.1%00.0%UnchangedHistory
DTDynatrace, Inc.Stock109,000$4.88M0.1%+73,000+202.8%AddedHistory
KLRSKalaris Therapeutics, Inc.COM6,597,167$4.77M0.1%00.0%UnchangedHistory
APLTApplied Therapeutics, Inc.COM1,009,500$4.71M0.1%00.0%UnchangedHistory
TSMTaiwan Semiconductor Manufacturing Co LtdADR26,000$4.52M0.1%−6,000−18.8%ReducedHistory
FHTXFoghorn Therapeutics Inc.COM720,720$4.14M0.1%00.0%UnchangedHistory
DDOGDatadog, Inc.CL A COM28,925$3.75M0.1%+19,325+201.3%AddedHistory
ANROAlto Neuroscience, Inc.COM SHS350,000$3.74M0.1%00.0%UnchangedHistory
AMZNAmazon Com IncStock19,250$3.72M0.1%+7,250+60.4%AddedHistory
FATEFate Therapeutics IncCOM1,032,500$3.39M0.1%+672,189+186.6%AddedHistory
HOOKHOOKIPA Pharma Inc.COM5,666,410$3.35M0.1%00.0%UnchangedHistory
ADCTADC Therapeutics SASHS1,018,461$3.22M0.1%+1,018,461NewHistory
BEKEKE Holdings Inc.SPONSORED ADS225,000$3.18M0.1%−50,000−18.2%ReducedHistory
RGNXREGENXBIO Inc.COM250,000$2.92M0.1%00.0%UnchangedHistory
OMGAOmega Therapeutics, Inc.COMMON STOCK1,323,530$2.74M0.1%00.0%UnchangedHistory
ELEVElevation Acquisition Group Inc.COM1,013,015$2.74M0.1%−500,000−33.0%ReducedHistory
KVUEKenvue Inc.Stock137,000$2.49M0.1%+137,000NewHistory
SGMTSagimet Biosciences Inc.COM SER A724,771$2.48M0.1%00.0%UnchangedHistory
CBIOCrescent Biopharma, Inc.COM8,589,064$2.42M0.1%00.0%UnchangedHistory
PCORProcore Technologies, Inc.COM32,300$2.14M0.1%+22,800+240.0%AddedHistory
NOWServiceNow, Inc.Stock2,500$1.97M0.1%+2,500NewHistory
OVIDOvid Therapeutics Inc.COM2,500,000$1.92M<0.1%00.0%UnchangedHistory
GRTSGritstone bio, Inc.COM3,030,952$1.87M<0.1%+2,000,000+194.0%AddedHistory
PEPGPepGen Inc.COM113,317$1.81M<0.1%−86,683−43.3%ReducedHistory
PANWPalo Alto Networks IncStock4,500$1.53M<0.1%+1,500+50.0%AddedHistory
KYTXKyverna Therapeutics, Inc.COM200,000$1.50M<0.1%00.0%UnchangedHistory
QCOMQualcomm IncStock7,500$1.49M<0.1%+7,500NewHistory
JBIOJade Biosciences, Inc.COM809,600$1.34M<0.1%+809,600NewHistory
GOOGLAlphabet Inc.Stock7,000$1.28M<0.1%00.0%UnchangedHistory
MGXMetagenomi Therapeutics, Inc.COM300,000$1.22M<0.1%00.0%UnchangedHistory
TRMLTourmaline Bio, Inc.COM91,426$1.18M<0.1%−223,070−70.9%ReducedHistory
RBRKRubrik, Inc.Stock35,000$1.07M<0.1%+35,000NewHistory
KRONKronos Bio, Inc.COM842,954$1.05M<0.1%00.0%UnchangedHistory
MDBMongoDB, Inc.CL A4,021$1.01M<0.1%+2,021+101.1%AddedHistory
EDUNew Oriental Education & Technology Group Inc.SPON ADR12,500$971.6K<0.1%−2,500−16.7%ReducedHistory
BZKanzhun LtdSPONSORED ADS50,000$940.5K<0.1%+50,000NewHistory
FROGJFrog LtdStock25,000$938.8K<0.1%+25,000NewHistory
PYPLPayPal Holdings, Inc.Stock15,000$870.5K<0.1%+5,000+50.0%AddedHistory
INTCIntel CorpStock25,000$774.3K<0.1%+25,000NewHistory
IRWDIronwood Pharmaceuticals IncCOM CL A110,532$720.7K<0.1%00.0%UnchangedHistory
PEGAPegasystems IncCOM11,500$696.1K<0.1%00.0%UnchangedHistory
SNOWSnowflake Inc.Stock5,051$682.3K<0.1%−1,449−22.3%ReducedHistory
Achilles Therapeutics PLC00449L102SPONSORED ADS755,375$615.6K<0.1%00.0%Unchanged–
CFLTConfluent, Inc.CLASS A COM19,000$561.1K<0.1%00.0%UnchangedHistory
CCCCCC Intelligent Solutions Holdings Inc.COM50,000$555.5K<0.1%+50,000NewHistory
METAMeta Platforms, Inc.Stock1,100$554.6K<0.1%+1,100NewHistory

Options (3)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Artal Group S.A. in Q2 2024
SecurityClassPutsCalls
ARWRArrowhead Pharmaceuticals, Inc.COM–$26.0M
PYPLPayPal Holdings, Inc.Stock–$1.51M
GOSSGossamer Bio, Inc.COM–$186.5K

Sold out since Q1 2024 (20)

Positions held at the end of Q1 2024 that are gone from this filing.

Positions of Artal Group S.A. sold out since Q1 2024
SecurityClassShares in Q1 2024Value in Q1 2024% of portfolio in Q1 2024History
MDGLMadrigal Pharmaceuticals, Inc.COM110,507$29.5M0.8%History
VKTXViking Therapeutics, Inc.COM253,863$20.8M0.5%History
ALPNAlpine Immune Sciences, Inc.COM405,784$16.1M0.4%History
ATXSAstria Therapeutics, Inc.COM884,214$12.4M0.3%History
FOLDAmicus Therapeutics, Inc.COM1,011,776$11.9M0.3%History
CLDXCelldex Therapeutics, Inc.COM NEW253,000$10.6M0.3%History
APGEApogee Therapeutics, Inc.COM152,500$10.1M0.3%History
GPCRStructure Therapeutics Inc.SPONSORED ADS151,780$6.51M0.2%History
AXSMAxsome Therapeutics, Inc.COM76,837$6.13M0.2%History
RNACCartesian Therapeutics, Inc.COM9,136,635$5.94M0.2%History
GERNGeron CorpCOM1,281,194$4.23M0.1%History
STOKStoke Therapeutics, Inc.COM300,000$4.05M0.1%History
RPTXRepare Therapeutics Inc.COM700,000$3.30M0.1%History
ADAGAdagene Inc.ADS1,020,000$2.86M0.1%History
VORVor Biopharma Inc.COM1,000,000$2.37M0.1%History
AAPLApple Inc.Stock10,000$1.71M<0.1%History
AMDAdvanced Micro Devices IncStock4,500$812.2K<0.1%History
CWANClearwater Analytics Holdings, Inc.CL A25,000$442.3K<0.1%History
HIPOHippo Holdings Inc.COM NEW24,000$438.5K<0.1%History
INKTMiNK Therapeutics, Inc.COM1,916$1.74K<0.1%History